1YONEMURA Y,FUSHIDA S, BANDO E,et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer[J]. Eur J Cancer,2001,37 : 918--923.
2NOGUCHI T, TAKENO S, SHIBATA T, et al. VEGF-C expression correlates with histological differentiation and metastasis in squamous cell carcinoma of the esophagus[J ]. Oneol Rep, 2002,9 : 995--999.
3OHNO M, NAKAMURA T, KUNIMOTO Y, et al. Lymphagenesis correlates with expression of vascular endothelial growth factor-C in colorectal cancer[J]. Oncol Rep, 2003,10: 939-- 943.
4NAKAMURA Y, YASUOKA H, TSUJIMOTO M, et al. Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up[J ]. Mod Pathol, 2003,16 : 309-- 314.
5PARTANEN T A, AROLA J, SAARISTO A, et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor,VEGFR-3, in fenestrated blood vessels in human tissues[J]. FASEB J, 2000, 14 : 2087 --2096.
6YANAI Y, FURUHATA T, KIMURA Y, et al. Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice[J]. J Exp Clin Cancer Res, 2001,20 : 419--428.
7HACHISUKA T, NARIKIYO M, YAMADA Y, et al. High lymphatic vessel density correlates with overexpression of VEGF-C in gastric eancer[J]. Oncol Rep, 2005,13:733--737.
9JUTTNER S,WISSMANN C,JONS T, et al. Vascular endothelial growth factor-D and its receptor VEGFR- 3 : two novel independent prognostic markers in gastric adenocarcinoma[J]. J Clin Oncol, 2006,24 : 228-- 240.
10ISHIKAWA M, KITAYAMA J, KAZAMA S, et al. Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important Hsk factor for lymphatic metastasis in undifferentiated early gastric carcinoma[J]. Jpn J Clin Oncol, 2003,33 : 21--27.
5Fosslien E. Molecular pathology of cyclooxygenase-2 in neoplasia. Ann Clin Lab Sci, 2000 , 90: 3 -21.
6Fujiwaki R, Iida K, Kanasaki H, et al. Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase. Hum Pathol, 2002, 33:213-219.
7Jaeckel EC, Raja S, Tan J, et al. Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg, 2001, 12
8Kawabe A, Shimada Y, Uchida S, et al. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression. J Surg Oncol, 2002, 80:79-
9Yu HG, Li JY, Yang YN,et al. Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer. Cancer Lett, 2003, 195:43-51.
10Li X, Eriksson U. Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D. Int J Biochem Cell Biol,2001,33:421-426.
2Kurahara H,Takao S,Maemura K,et al.Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer:its relationship to lymph nodemetastasi[J].Clin Cancer Res,2004,10(24):8413-8420.
3Yashiro M,Shinto O,Nakamural K,et al.Effects of VEGFR-3phosphorylation inhibitoron lymph node metastasis in an orthotopic diffuse-type gastric carcinomamodel[J].Br J Cancer,2009,101(7):1100-1106.
4Donnem T,AI-Saad S,AI-Shibli K,et al.Co-expression of PDGF-B and VEGFR-3 strongly correlates with lymph nodemetastasis and poor survival in non-small-cell lung cancer[J].Ann Oncol,2010,21(2):223-231.
5Kodama M,Kitadai Y,Tanaka M,et al.Vascular endothelialgrowth factor C stimulates progression of human gastric cancervia both autocrine and paracrine mechanisms[J].Clin Cancer Res,2008,14(22):7205-7214.
